Zero Candida Technologies

Bringing women’s healthcare into the 21st century 🌸 $ZCT.V #ZCTFF

[Zero Candida Technologies @ZeroCandida]

Incredible opportunity opening the @tsx_tsxv in celebration of our #newlisting yesterday! Thank you to our team, partners, and investors - this milestone marks a key step in our mission to revolutionize #femalehealthcare … Excited to share what’s next for #ZCT 🎊📈

[Zero Candida Technologies @ZeroCandida]

$ZCT.V $ZCTFF

#ZeroCandida has begun prototype production of ZC-001, the first #AI-enabled #FemTech device combining blue light, #drugdelivery, & wireless diagnostics for personalized #VVC treatment. 🩺

50 units in progress ☑️ Q1 2026 completion

🔗https://t.co/7FpNjZ2rmx

[Zero Candida Technologies @ZeroCandida]

$ZCT.V $ZCTFF

#FemTechTuesday 🌸

This series will explore the unmet needs, market trends, and tech driving #FemTech innovation - and how #ZeroCandida is making change in #WomensHealth 🩺

From overlooked to one of the fastest-growing opportunities in healthcare. Watch now ⏯️

[Virtual Investor Conferences @RIConferences]

Join the OTCQB Venture Virtual Investor Conference at 10am ET today. Presentations by: @SurgeCopper @Silver47co @natures63491 @ZeroCandida @nxtgn_digital @TeloGenomics @zomedica @wasteenergycorp @CleangoInno @sekurprivate @cybercatch_

Register: https://t.co/CTMfwB693p

[Zero Candida Technologies @ZeroCandida]

We’re looking forward to presenting at the #OTCQB Venture Virtual Investor Conference hosted by @RIConferences and @OTCMarkets this Thursday!

📆 Aug 7, 2025
⏱️ 12:00 PM ET

🎥 Join us #LIVE by registering via https://t.co/olYJqgLMWv

$ZCTFF $ZCT.V #ZeroCandida #MedTech

[Pharm. Greatman @OGreat6]

VAGINAL CANDIDIASIS

You cannot skip the candida conversation when discussing infections that affect ladies.

This thread explains all you need to know about vaginal candidiasis (yeast infection) and how to keep it under control!

A thread

[Cision/PR Newswire Israel @PRNewswireIL]

#Zero #Candida #Technologies #Reports #Full #Year 2024 #Financial #Results and #Business #Highlights https://t.co/JABe4DMzLJ $ZCT @ZeroCandida

[INN Life Science @INN_LifeScience]

With 75% of women experiencing vulvovaginal candidiasis, the market potential is immense. The antifungal drugs market is valued at $15.8B and projected to grow. Don't miss out on this transformative opportunity! https://t.co/PcHJYcMwBs

#WomensHealth #Investing @ZeroCandida #ZCT $ZCT

[Proactive @proactive_x]

Zero Candida begins trading on OTCQB, advances AI-driven women’s health solutions @ZeroCandida #TSXV #OTCQB #ZCT #ZCTFF https://t.co/5hzMtSZSEW

[Zero Candida Technologies @ZeroCandida]

Healthcare investment strategies reshaped by inflation, interest rates and M&A in 2025 https://t.co/zLfJJhUOVD

[Zero Candida Technologies @ZeroCandida]

Zero Candida is now trading on the #OTCQB under $ZCTFF 🔑 This listing is a key driver in transforming women’s health and answering the significant US demand for innovation in the #VVC treatment market. See the opportunity:
https://t.co/ciFwDPp2QM

[Cision/PR Newswire Israel @PRNewswireIL]

#Zero #Candida #Commences #Trading on #OTCQB #Market https://t.co/MsrmZFpGIB $ZCT @ZeroCandida

[INN Life Science @INN_LifeScience]

With 75% of women experiencing vulvovaginal candidiasis, the market potential is immense. The antifungal drugs market is valued at $15.8B and projected to grow. Don't miss out on this transformative opportunity! https://t.co/PcHJYcMwBs

#WomensHealth #Investing @ZeroCandida #ZCT $ZCT

[InvestorIdeas.com @InvestorIdeas]

Investor Ideas New #StockstoWatch in #LifeSciences and #AI
February 14, 2025 (https://t.co/dB77uPuQvh Newswire) https://t.co/dB77uPuQvh, a global news source and expert investing resource, announces today's roundup of stocks to watch in the Life Sciences and AI sectors.

📷

The newest life sciences companies are involved in woman's health, microbiology testing, cannabinoid pharmaceuticals and drug development using AI.

The latest AI companies are involved in autonomous robotics, AI/sensor technology and marketing and business solutions.

New stocks added today: Zero Candida Technologies Inc. (TSXV:ZCT), Innovotech, Inc. (TSXV: $IOT.V), SciSparc Ltd. (Nasdaq: $SPRC), Bioxytran, Inc. (OTCQB: $BIXT) Nauticus Robotics, Inc. (NASDAQ: $KITT), Realbotix Corp. (TSX-V: $BOT;.V OTC: $XBOTF), Wytec International, Inc. (OTCQB: $WYTC), Onar, Inc. (OTCQB: $RELT).

https://t.co/E8tzKbhDpX

[Proactive USA @proactive_NA]

Vulvovaginal candidiasis market poised for $2B growth by 2030 @ZeroCandida #TSXV #ZCT https://t.co/HvoOI6QMyI

[Proactive USA @proactive_NA]

Market growth spurs innovation in vulvovaginal candidiasis therapies @ZeroCandida #TSXV #ZCT https://t.co/pCgqVYwxIC

[INN Life Science @INN_LifeScience]

Exciting advancements in antifungal treatments are revolutionizing women's health! With 75% of women affected by VVC, the market is ripe for innovation. Discover how new therapies and investment opportunities are shaping the future of healthcare! #WomensHealth #Investing @ZeroCandida $ZCT #ZCT https://t.co/PcHJYcMwBs

[Proactive USA @proactive_NA]

Zero Candida market could reach $2B by 2030, Moore Financial says @ZeroCandida #TSXV #ZCT https://t.co/f1AwVkoCgI

[INN Life Science @INN_LifeScience]

With 75% of women experiencing vulvovaginal candidiasis, the market potential is immense. The antifungal drugs market is valued at $15.8B and projected to grow. Don't miss out on this transformative opportunity! https://t.co/PcHJYcMwBs

#WomensHealth #Investing @ZeroCandida #ZCT $ZCT

[Proactive USA @proactive_NA]

Zero Candida eyes FDA submission following upcoming human trials of AI-powered Candida treatment device @ZeroCandida #TSXV #ZCT https://t.co/IjBUeA2y9E

[Proactive USA @proactive_NA]

Zero Candida prepares AI-powered candida therapy for market debut @ZeroCandida #TSXV #ZCT https://t.co/vM8QqB5cxz